Externally sourcing research through acquisition: Should it supplement or substitute for internal research?

Industry and Innovation

Volumn 15, Issue 6, 2008, Pages 627-645

  Ruckman, Karen ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

Author keywords

Acquisitions; Performance; Pharmaceuticals; Research and development; Resource based view; Technology sourcing

Indexed keywords

BIOTECHNOLOGY; INDUSTRIAL PERFORMANCE; OUTSOURCING; PHARMACEUTICAL INDUSTRY; PROFITABILITY; RESEARCH AND DEVELOPMENT;

NORTH AMERICA; UNITED STATES;

EID: 57749092105     PISSN: 13662716     EISSN: 14698390     Source Type: Journal    
DOI: 10.1080/13662710802550976     Document Type: Article

References (55)

1. Agrawal, A. and Jaffe, J. F. (2000) The post-merger performance puzzle. Advances in Mergers and Acquisitions, pp. 7-42. Elsevier Science, New York
2. Ahuja, G. and Katila, R. (2001) Technological acquisitions and the innovation performance of acquiring firms: A longitudinal study. Strategic Management Journal, 22:3, pp. 197-220.
3. Appleyard, M. M. (1996) How does knowledge flow? Interfirm patterns in the semiconductor industry. Strategic Management Journal, 17, pp. 137-154.
4. Arthur, W. B. (1989) Competing technologies, increasing returns and lock-in by historical events. Economic Journal, 99, pp. 116-131.
5. Barney, J. B. (1991) Firm resources and sustained competitive advantage. Journal of Management, 7, pp. 49-64.
6. Bercovitz, J. and Mitchell, W. (2007) When is more better? The impact of business scale and scope on long-term business survival, while controlling for profitability. Strategic Management Journal, 28, pp. 61-79.
7. Bower, J. L. (2001) Not all M&As are alike-and that matters. Harvard Business Review, pp. 93-101.
8. Capon, N., Hulbert, J. M., Farley, J. U. and Martin, I. E. (1988) Corporate diversity and economic performance: The impact of market specialization. Strategic Management Journal, 9:1, pp. 61-74.
9. Capron, L. (1999) The long-term performance of horizontal acquisitions. Strategic Management Journal, 20, pp. 987-1018.
10. Cassiman, B., Colombo, M., Garrone, P. and Veugelers, R. (2005) The impact of M&A on the R&D process: An empirical analysis of the role of technological- and market-relatedness. Research Policy, 34:2, pp. 195-220.
11. Center for Drug and Research Evaluation (1997) Factbook 1997, US Department of Health and Human Services, Food and Drug Administration, Beltsville, MD
12. Chatterjee, S., Lubatkin, M. H., Schweiger, D. M. and Weber, Y. (1992) Cultural differences and shareholder value in related mergers: Linking equity and human capital. Strategic Management Journal, 13, pp. 319-334.
13. Chaudhuri, S. and Tabrizi, B. (1999) Capturing the real value in high-tech acquisitions. Harvard Business Review, 77:5, pp. 123-130.
14. Christiansen, C. and Rosenbloom, R. (1995) Explaining the attacker's advantage: Technological paradigms, organizational dynamics, and the value network. Research Policy, 24, pp. 233-257.
15. Cohen, W. M. and Levinthal, D. A. (1989) Innovation and learning: The two faces of R&D. Economic Journal, 99, pp. 569-596.
16. Cohen, W. M. and Levinthan, D. A. (1990) Absorptive capacity: A new perspective on learning and innovation. Administrative Science Quarterly, 35, pp. 128-152.
17. Deloitte Consulting (2006)
18. Dierickx, I. and Cool, K. (1989) Asset stock accumulation and sustainability of competitive advantage. Management Science, 35, pp. 1504-1511.
19. Ernst & Young (2006) Beyond Borders: Global Biotechnology Report 2006, Ernst & Young, Palo Alto, CA
20. Fiegenbaum, A. and Thomas, H. (1988) Attitudes toward risk and the risk-return paradox: Prospect theory explanations. Academy of Management Journal, 31, pp. 85-106.
21. Giovannetti, G. and Morrison, S. (2000) Convergence: The Biotechnology Industry Report, Ernst & Young, Palo Alto, CA
22. Gupta, D. and Gerchak, Y. (2002) Quantifying operational synergies in a merger/acquisition. Management Science, 48, pp. 517-533.
23. Harrison, J., Hitt, M., Hoskisson, R. and Ireland, R. (1991) Synergies and post-acquisition performance: Differences versus similarities in resource allocations. Journal of Management, 17:1, pp. 173-190.
24. Hartmann, M. and Hassan, A. (2006) Application of real options analysis for pharmaceutical R&D project valuation-empirical results from a survey. Research Policy, 35, pp. 343-354.
25. Haspeslagh, P. C. and Jemison, D. B. (1991) Managing Acquisitions: Creating Value through Corporate Renewal, Free Press, New York
26. Henderson, R. and Cockburn, I. (1994) Measuring competence? Exploring firm effects in pharmaceutical research. Strategic Management Journal, 15, pp. 63-84.
27. Higgins, M. and Rodriguez, D. (2006) The outsourcing of R&D through acquisitions in the pharmaceutical industry. Journal of Financial Economics, 80:2, pp. 351-383.
28. Hitt, M., Hoskisson, R., Ireland, R. and Harrison, J. (1991) Effects of acquisitions on R&D inputs and outputs. Academy of Management Journal, 34:3, pp. 693-706.
29. Hoskisson, R. E., Hitt, M. A., Johnson, R. A. and Moesel, D. D. (1993) Construct validity of an objective (entropy) categorical measure of diversification strategy. Strategic Management Journal, 14:3, pp. 215-235.
30. Hsiao, C. (1986) Analysis of Panel Data, Cambridge University Press, Cambridge
31. Inkpen, A. C., Sundaram, A. K. and Rockwood, K. (2000) Cross-border acquisitions of U.S. technology assets. California Management Review, 42:3, pp. 50-71.
32. Jacob, W. and Kwak, Y. (2003) In search of innovative techniques to evaluate pharmaceutical R&D projects. Technovation, 23, pp. 291-296.
33. King, D. R., Dalton, D. R., Daily, C. M. and Covin, J. G. (2004) Meta-analyses of post-acquisition performance: Indicators of unidentified moderators. Strategic Management Journal, 25, pp. 187-200.
34. King, D. R., Slotegraaf, R. J. and Kesner, I. (2008) Performance implications of firm resource interactions in the acquisition of R&D-intensive firms. Organizational Science, 19:2, pp. 327-340.
35. Larsson, R. and Finkelstein, S. (1999) Integrating strategic, organizational, and human resource perspectives on mergers and acquisitions: A case survey of synergy realization. Organization Science, 10, pp. 1-26.
36. Levinthal, D. and March, J. (1993) The myopia of learning. Strategic Management Journal, 14, pp. 95-112.
37. Lubatkin, M. (1983) Mergers and the performance of the acquiring firm. Academy of Management Review, 8, pp. 218-225.
38. Penner-Hahn, J. and Shaver, J. M. (2005) Does international research and development increase patent output? An analysis of Japanese pharmaceutical firms. Strategic Management Journal, 26, pp. 121-140.
39. Peteraf, M. A. (1993) The cornerstones of competitive advantage: A resource based view. Strategic Management Journal, 14, pp. 179-191.
40. Prabhu, J., Chandy, R. and Ellis, M. (2005) The impact of acquisitions on innovation: Poison pill, placebo or tonic. Journal of Marketing, 69, pp. 114-130.
41. Ranft, A. and Lord, M. (2002) Acquiring new technologies and capabilities: A grounded model of acquisition implementation. Organization Science, 13:4, pp. 420-441.
42. Rothaermel, F. and Deeds, D. (2004) Exploration and exploitation alliances in biotechnology: A system of new product development. Strategic Management Journal, 35:3, p. 201.
43. Rothaermel, F. and Hill, C. (2005) Technological discontinuities and complementary assets: A longitudinal study of industry and firm performance. Organization Science, 16:1, pp. 52-70.
44. Ruckman, K. (2007) Acquiring biopharmaceutical research: Is market approval a deal breaker?. Advances in Mergers and Acquisitions, Elsevier JAI Press, Oxford
45. Schumpeter, J. (1961) Theory of Economic Development, Oxford University Press, New York
46. Schweiger, D. M. and Walsh, J. P. (1990) Mergers and acquisitions: An interdisciplinary view. Research in Personnel and Human Resource Management, 8, pp. 41-107.
47. Schweizer, L. (2005) Organizational integration of acquired biotechnology companies into pharmaceutical companies: The need for a hybrid approach. Academy of Management Journal, 48:6, pp. 1051-1074.
48. Sigglekow, N. (2002) Misperceiving interactions among complements and substitutes: Organizational consequences. Management Science, 48, pp. 900-916.
49. Sorescu, A. B., Chandy, R. K. and Prabhu, J. C. (2007) Why some acquisitions do better than others: Product capital as a driver of long-term stock returns. Journal of Marketing Research, pp. 57-72.
50. Tiwana, A. and Keil, M. (2007) Does peripheral knowledge complement control? An empirical test in technology outsourcing alliances. Strategic Management Journal, 28, pp. 623-634.
51. Walsh, J. P. (1988) Top management turnover following mergers and acquisitions. Strategic Management Journal, 9, pp. 173-183. 173-183.
52. Wooldridge, J. (2000) Introductory Econometrics: A Modern Approach, South-Western College Publishing, a division of Thomson Learning, Cincinnati
53. Yeoh, P. -L. and Roth, K. (1999) An empirical analysis of sustained advantage in the U.S. pharmaceutical industry: Impact of firm resources and capabilities. Strategic Management Journal, 20, pp. 637-653.
54. Zahra, S. (1996) Technology strategy and performance: Examining the moderating role of a firm's competitive environment. Journal of Business Venturing, 11, pp. 189-219.
55. Zahra, S. and George, G. (2002) Absorptive capacity: A review, reconceptualization, and extension. Academy of Management Review, 27, pp. 185-203.